The use of mycophenolate mofetil in treating patients with non responding aplastic anemia
Aplastic anemia is a relatively uncommon disease and conventional management options include immunosuppressive drugs and/or haematopoeitic stem cell transplantation. It is now known that the pathogenesis of aplastic anemia is immune mediated. Mycophenolate mofetil is a common immunosuppressive drug...
Autori principali: | Gan, Gin Gin, Leong, C.F., Sangkar, J.V., Teh, A., Goh, K.Y., Cheong, S.K. |
---|---|
Natura: | Articolo |
Lingua: | English |
Pubblicazione: |
Malaysian Medical Association
2005
|
Soggetti: | |
Accesso online: | http://eprints.um.edu.my/24590/1/Aplastic_Anemia.pdf |
Documenti analoghi
Documenti analoghi
-
Mycophenolate mofetil induced transfusion dependent anemia in lupus
di: Anand Prahalad Rao, et al.
Pubblicazione: (2018-01-01) -
Mycophenolate mofetil and atherosclerosis
di: Z S Alekberova, et al.
Pubblicazione: (2009-10-01) -
Familial hemophagocytic lymphohistiocytosis in two brothers
di: Gan, Gin Gin, et al.
Pubblicazione: (2004) -
Severe Relapsing Goodpasture's Disease Successfully Treated with Mycophenolate Mofetil
di: Anabela Malho, et al.
Pubblicazione: (2010-01-01) -
Esophageal Cicatricial Pemphigoid as an Isolated Involvement Treated with Mycophenolate Mofetil
di: Sandra Sánchez Prudencio, et al.
Pubblicazione: (2015-01-01)